107 related articles for article (PubMed ID: 7554298)
1. Serum concentrations of the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in chronic liver disease.
Hayasaka A; Iida S; Ohto M
Clin Chim Acta; 1995 Jun; 238(1):85-90. PubMed ID: 7554298
[No Abstract] [Full Text] [Related]
2. Clinical significance of serum 7S collagen in various liver diseases.
Yamada S; Suou T; Kawasaki H; Yoshikawa N
Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma.
Hosoya Y; Arai K; Honda M; Sumi S; Yoshida K
Eur Urol; 1997; 31(2):220-3. PubMed ID: 9076470
[TBL] [Abstract][Full Text] [Related]
4. Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations.
Stevenson HP; Leslie H; Sheridan B
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():317-8. PubMed ID: 9158832
[No Abstract] [Full Text] [Related]
5. Effect of growth hormone (GH) replacement on plasma carboxy-terminal propeptide of type I procollagen (PICP) and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) levels in GH-deficient adult patients.
Murakami Y; Sugitani M; Koshimura K; Sohmiya M; Kato Y
Endocr J; 1998 Apr; 45 Suppl():S121-4. PubMed ID: 9790245
[No Abstract] [Full Text] [Related]
6. The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis.
Ricard-Blum S; Chossegros P; Guerret S; Trepo C; Grimaud JA; Chevallier M
Clin Chim Acta; 1996 Apr; 248(2):187-95. PubMed ID: 8740582
[TBL] [Abstract][Full Text] [Related]
7. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
Ueno T; Hashimoto O; Sugawara H; Ogata R; Kusaba N; Torimura T; Sata M; Tanikawa K
Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125
[TBL] [Abstract][Full Text] [Related]
8. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
[TBL] [Abstract][Full Text] [Related]
9. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
10. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
11. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
13. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
14. [Significance and limitations of the radioimmunologic determination of the aminoterminal peptide of procollagen III in chronic hepatopathies].
Rossi L; Degen C; Lorenzin F; Milani A; Siciliano M
Ann Ital Med Int; 1988; 3(3):203-7. PubMed ID: 3152857
[No Abstract] [Full Text] [Related]
15. Method-specific differences in β-isomerised carboxy-terminal cross-linking telopeptide of type I collagen and procollagen type I amino-terminal propeptide using two fully automated immunoassays.
Wheater G; Goodrum C; Tuck SP; Datta HK; van Laar JM
Clin Chem Lab Med; 2014 Jul; 52(7):e135-8. PubMed ID: 24566364
[No Abstract] [Full Text] [Related]
16. [Serum level of N-terminal peptide of procollagen type III in chronic liver disease].
Lee CM; Liaw YF; Huang MJ; Chen TJ; Chu CM; Sheen IS; Lin HH
Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):769-73. PubMed ID: 3681243
[No Abstract] [Full Text] [Related]
17. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
[TBL] [Abstract][Full Text] [Related]
18. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
19. Collagen turnover after tibial fractures.
Joerring S; Krogsgaard M; Wilbek H; Jensen LT
Arch Orthop Trauma Surg; 1994; 113(6):334-6. PubMed ID: 7833212
[TBL] [Abstract][Full Text] [Related]
20. Serum collagenase activity in patients with chronic liver disease.
Murawaki Y; Koda M; Yamada S; Kawasaki H; Shima H; Burkhardt H
J Hepatol; 1993 Jul; 18(3):328-34. PubMed ID: 8228126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
